Tonix Pharmaceuticals Holding (TNXP): Prakiraan gabungan firma investasi

Tonix Pharmaceuticals (TNXP) is a diversified biotech business. The price trend illustrated in this chart is based on the development of cutting-edge drugs to combat brain pathologies and infections, where the indicator stands at 44.17. The company is currently radically changing its management model to preserve capital and accelerate final drug trials. Operational flexibility is achieved by fully outsourcing production and research to third-party contractors.

TNXP (Tonix Pharmaceuticals Holding) riwayat Bagan rega target saka 04.07.2022 nganti 22.10.2026

Rincian analitis perusahaan Tonix Pharmaceuticals Inc. (TNXP)

TNXP — sistem indikator bursa lan keuangan Tonix Pharmaceuticals Holding:

Rega tonixpharma.com|TNXP - Bagan rega target|Kapitalisasi pasar Tonix Pharmaceuticals Inc.

Analisis umum perusahaan:TNXP tonixpharma.com

Barang unggulan Tonix Pharmaceuticals Holding

The consensus forecast represents an aggregated market valuation of an asset based on the discounting of future cash flows and the expectations of the expert community. The diversified development portfolio of Tonix Pharmaceuticals (TNXP) and government funding stabilize the analysts' consensus on the share price on GURU.Markets, allowing investors to assess capital stability through the dynamics of how forecasts adapt to new clinical data.

Pesaing Tonix Pharmaceuticals

Rega prakiraan analis HLN|Bagan rega target Kenvue KVUE|VRNA: Prakiraan gabungan firma investasi|MENS: Target konsensus|LGND (Ligand Corp) - Prakiraan gabungan firma investasi|Amneal Pharmaceuticals (AMRX) - Bagan rega target|Bagan tingkat prakiraan PRGO (perrigo.com)|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Konsensus nilai wajar|Bagan rega target BioHarvest BHST|Invizyne (EXOZ) - Rata-rata rega prakiraan|ORMP: Target konsensus|Entera Bio Ltd. - Rega prakiraan analis|HYFT: Prakiraan konsensus analis|ABVC BioPharma Inc. - Konsensus nilai wajar|CPIX (Cumberland Pharma) - Prakiraan konsensus analis|Rata-rata rega prakiraan Quantum BioPharma Corp QNTM|Bagan rega target FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Konsensus nilai wajar|Rani Therapeutics Holdings, Inc. - Target konsensus|Rega prakiraan analis SNYR (Synergy CHC Corp.)|RLYB - Bagan rega target|Rata-rata rega prakiraan Lexaria Bioscience|Pulmatrix, Inc. (PULM) - Bagan rega target|Prakiraan gabungan firma investasi PTHL|APM (Aptorum Group Ltd) - Prakiraan konsensus analis|Lyra Therapeutics Inc. (LYRA) - Target median analis|Target konsensus IBO (Impact BioMedical Inc)|tnfpharma.com - Prakiraan gabungan firma investasi|cbdMD - Target konsensus|Konsensus nilai wajar PRFX|CYTO - Bagan rega target|Bagan tingkat prakiraan LIPO|OPTN: Prakiraan konsensus analis|Pieris Pharma - Konsensus nilai wajar|PROC (Procaps Group S.A.) - Prakiraan konsensus analis|Prakiraan konsensus analis petrospharma.com|Bagan rega target Qilian International Holding (QLI)|SLRN (Acelyrin Inc.) - Konsensus nilai wajar|Bagan rega target TFF Pharma TFFP